Institute for Immunology, Medical Faculty Carl Gustav Carus, University of Technology Dresden, Dresden, Germany.
Clin Exp Immunol. 2014 Jan;175(1):9-16. doi: 10.1111/cei.12147.
Aicardi-Goutières syndrome (AGS) is a hereditary autoimmune disease which overlaps clinically and pathogenetically with systemic lupus erythematosus (SLE), and can be regarded as a monogenic variant of SLE. Both conditions are characterized by chronic activation of anti-viral type I interferon (IFN) responses. AGS can be caused by mutations in one of several genes encoding intracellular enzymes all involved in nucleic acid metabolism. Mouse models of AGS-associated defects yielded distinct phenotypes and reproduced important features of the disease. Analysis of these mutant mouse lines stimulated a new concept of autoimmunity caused by intracellular accumulations of nucleic acids, which trigger a chronic cell-intrinsic antiviral type I IFN response and thereby autoimmunity. This model is of major relevance for our understanding of SLE pathogenesis. Findings in gene-targeted mice deficient for AGS associated enzymes are summarized in this review.
Aicardi-Goutières 综合征(AGS)是一种遗传性自身免疫性疾病,在临床上和发病机制上与系统性红斑狼疮(SLE)重叠,可被视为 SLE 的单基因变异。这两种疾病的特征均为慢性激活抗病毒 I 型干扰素(IFN)应答。AGS 可由编码参与核酸代谢的几种细胞内酶的基因突变引起。AGS 相关缺陷的小鼠模型产生了不同的表型并再现了该疾病的重要特征。对这些突变小鼠系的分析激发了一种新的自身免疫概念,即由细胞内核酸积累引发的自身免疫,从而引发慢性细胞内抗病毒 I 型 IFN 应答和自身免疫。该模型对于我们理解 SLE 发病机制具有重要意义。本文总结了针对 AGS 相关酶缺乏的基因靶向小鼠的研究结果。